<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>460</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15542644</PubmedId>
            <Abstract>The epitope determinants of chimpanzee Fab antibody 1A5, which have been shown to be broadly reactive to flaviviruses and efficient for cross-neutralization of dengue virus type 1 and type 2 (DENV-1 and DENV-2), were studied by analysis of DENV-2 antigenic variants. Sequence analysis showed that one antigenic variant contained a Gly-to-Val substitution at position 106 within the flavivirus-conserved fusion peptide loop of the envelope protein (E), and another variant contained a His-to-Gln substitution at position 317 in E. Substitution of Gly(106)Val in DENV-2 E reduced the binding affinity of Fab 1A5 by approximately 80-fold, whereas substitution of His(317)Gln had little or no effect on antibody binding compared to the parental virus. Treatment of DENV-2 with beta-mercaptoethanol abolished binding of Fab 1A5, indicating that disulfide bridges were required for the structural integrity of the Fab 1A5 epitope. Binding of Fab 1A5 to DENV-2 was competed by an oligopeptide containing the fusion peptide sequence as shown by competition enzyme-linked immunosorbent assay. Both DENV-2 antigenic variants were shown to be attenuated, or at least similar to the parental virus, when evaluated for growth in cultured cells or for neurovirulence in mice. Fab 1A5 inhibited low pH-induced membrane fusion of mosquito C6/36 cells infected with DENV-1 or DENV-2, as detected by reduced syncytium formation. Both substitutions in DENV-2 E lowered the pH threshold for membrane fusion, as measured in a fusion-from-within assay. In the three-dimensional structure of E, Gly(106) in domain II and His(317) in domain III of the opposite E monomer were spatially close. From the locations of these amino acids, Fab 1A5 appears to recognize a novel epitope that has not been mapped before with a flavivirus monoclonal antibody.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>12919-28</ArticlePages>
            <ArticleTitle>Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Goncalvez</LastName>
                    <ForeName>Ana P</ForeName>
                </Author>
                <Author>
                    <LastName>Purcell</LastName>
                    <ForeName>Robert H</ForeName>
                </Author>
                <Author>
                    <LastName>Lai</LastName>
                    <ForeName>Ching-Juh</ForeName>
                </Author>
            </Authors>
            <Affiliations>Molecular Viral Biology Section, Laboratory of Infectious Diseases, NIAID, NIH, Building 50, Room 6349, 50 South Dr., MSC 8009, Bethesda, MD 20892, USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;E-glycoprotein, Dengue virus type 2;Immunoglobulin Fab Fragments;Viral Envelope Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(immunology); Dengue Virus(growth &amp; development; immunology); Epitope Mapping; Immunoglobulin Fab Fragments(immunology); Membrane Fusion; Mice; Molecular Sequence Data; Neutralization Tests; Pan troglodytes; Viral Envelope Proteins(chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>78</Volume>
                <Issue>23</Issue>
                <Title>Journal of virology</Title>
                <Issn>1098-5514</Issn>
                <MedlineTa>J Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Dengue Virus Fab 1A5 epitope</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>G106, L107, H317</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>ABX25775.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11060</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2A</LocationOfData>
                <EpitopeId>110496</EpitopeId>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <EpitopeComments>Genomic and protein sequence depicted above refer to Dengue Virus Type 2.  However, critical residues encompassing paratope are valid for Dengue Virus types 1, 2, 3, and 4.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>2479</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9598</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DENV-4 full length infectious RNA transcript</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>Single immunization with RNA transcript, folowed 9.5 months later by one subsequent immunization with live DENV-1, DENV-2, and DENV-3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Fab display library was generated from bone marrow lymphocytes of Chimpanzees which were intrahepatically transfected with full length DENV-4 RNA and subsequently infected subcutanteously with mixture of DENV-1 (Western Pacific strain), DENV-2  (New Guinea C strain prototype), and DENV-3 (strain H87).  Fab 1A5 antibody identified by panning Chimpanzee phage display library with DENV-2.  Affinity purified 6X-His Tagged Fab 1A5 was used for experiments.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The neutralization of live virus was measured with a reaction mixture used to infect Simian Vero cells.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Fab 1A5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Dengue virus group</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11060</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>2483</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9598</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DENV-4 full length infectious RNA transcript</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>Single immunization with RNA transcript, followed 9.5 months later by one subsequent immunization with live DENV-1, DENV-2, and DENV-3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Fab display library was generated from bone marrow lymphocytes of Chimpanzees which were intrahepatically transfected with full length DENV-4 RNA and subsequently infected subcutanteously with mixture of DENV-1 (Western Pacific strain), DENV-2  (New Guinea C strain prototype), and DENV-3 (strain H87).  Fab 1A5 antibody was  identified by panning Chimpanzee phage display library with DENV-2.  Affinity purified 6X-His Tagged Fab 1A5 was used for experiments.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>37</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A comparative analysis of Fab reactivity to Dengue Virus Type 2 (NGB strain) and Dengue virus antigenic variants was performed.  Reactivities were also compared by ELISA with similar results.  The results illustrate G106 as an important residue involved in antibody binding.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Fab 1A5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Dengue virus group</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11060</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>18072</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9598</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DENV-4 full length infectious RNA transcript</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>Single immunization with RNA transcript, folowed 9.5 months later by one subsequent immunization with live DENV-1, DENV-2, and DENV-3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Fab display library was generated from bone marrow lymphocytes of Chimpanzees which were intrahepatically transfected with full length DENV-4 RNA and subsequently infected subcutanteously with mixture of DENV-1 (Western Pacific strain), DENV-2  (New Guinea C strain prototype), and DENV-3 (strain H87).  Fab 1A5 antibody identified by panning Chimpanzee phage display library with DENV-2.  Affinity purified 6X-His Tagged Fab 1A5 was used for experiments.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Inhibition of fusion activity (syncytium formation) of DENV-2 and variants in infected C3/36 cell monolayers across a pH range of 5.5-8 was used to assess the relative importance of residues within the epitope.  Both variants resulted in a change in the binding curve from non-sigmoidal, but neither had an overall result of complete inhibition of fusion.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Fab 1A5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Dengue virus group</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11060</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 8</LocationOfData>
                        <BCellId>18074</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9598</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DENV-4 full length infectious RNA transcript</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>Single immunization with RNA transcript, folowed 9.5 months later by one subsequent immunization with live DENV-1, DENV-2, and DENV-3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Fab display library was generated from bone marrow lymphocytes of Chimpanzees which were intrahepatically transfected with full length DENV-4 RNA and subsequently infected subcutanteously with mixture of DENV-1 (Western Pacific strain), DENV-2  (New Guinea C strain prototype), and DENV-3 (strain H87).  Fab 1A5 antibody identified by panning Chimpanzee phage display library with DENV-2.  Affinity purified 6X-His Tagged Fab 1A5 was used for experiments.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Binding activity and neutralization capacity of Fab 1A5 to DENV-4 and antigenic variants illustrate the importance of residues G106 and L107 in the fusion loop.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Fab 1A5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Dengue Virus Type 4</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11070</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>2488</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9598</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11070</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>DENV-4 full length infectious RNA transcript</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <DoseSchedule>Single immunization with RNA transcript, folowed 9.5 months later by one subsequent immunization with live DENV-1, DENV-2, and DENV-3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Fab display library was generated from bone marrow lymphocytes of Chimpanzees which were intrahepatically transfected with full length DENV-4 RNA and subsequently infected subcutanteously with mixture of DENV-1 (Western Pacific strain), DENV-2  (New Guinea C strain prototype), and DENV-3 (strain H87).  Fab 1A5 antibody identified by panning Chimpanzee phage display library with DENV-2.  Affinity purified 6X-His Tagged Fab 1A5 was used for experiments.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>311</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Inhibition of Fab 1A5 binding to Denv-2 by fusion peptide in a competition assay was demonstrated.  Fusion peptide did compete with a 50% inhibition of binding at approximately 800 nM fusion peptide.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>Fab 1A5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>CD Loop peptide aa 98-109</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Other Structure from Source Organism</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DRGWGNGCGLFG</LinearSequence>
                                        <StartingPosition>98</StartingPosition>
                                        <EndingPosition>109</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P14339.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11060</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

